These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2600539)

  • 1. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis.
    Salen G; Shore V; Tint GS; Forte T; Shefer S; Horak I; Horak E; Dayal B; Nguyen L; Batta AK
    J Lipid Res; 1989 Sep; 30(9):1319-30. PubMed ID: 2600539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis. Comparison with lovastatin.
    Nguyen L; Salen G; Shefer S; Shore V; Tint GS; Ness G
    Arteriosclerosis; 1990; 10(2):289-97. PubMed ID: 2317163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of dietary sitosterol on plasma sterols and cholesterol and bile acid synthesis in a sitosterolemic homozygote and heterozygote subject.
    Cobb MM; Salen G; Tint GS
    J Am Coll Nutr; 1997 Dec; 16(6):605-13. PubMed ID: 9430090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis.
    Gregg RE; Connor WE; Lin DS; Brewer HB
    J Clin Invest; 1986 Jun; 77(6):1864-72. PubMed ID: 3711338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters.
    Bhattacharyya AK; Connor WE
    J Clin Invest; 1974 Apr; 53(4):1033-43. PubMed ID: 4360855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia.
    Salen G; Tint GS; Shefer S; Shore V; Nguyen L
    Arterioscler Thromb; 1992 May; 12(5):563-8. PubMed ID: 1576118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool of sitosterol in patients with sitosterolemia and xanthomatosis.
    Bhattacharyya AK; Connor WE; Lin DS; McMurry MM; Shulman RS
    Arterioscler Thromb; 1991; 11(5):1287-94. PubMed ID: 1911714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibition of hepatic sterol 27-hydroxylase by sitosterol: decreased activity in sitosterolemia.
    Nguyen LB; Shefer S; Salen G; Tint SG; Batta AK
    Proc Assoc Am Physicians; 1998; 110(1):32-9. PubMed ID: 9460081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis.
    Salen G; Horak I; Rothkopf M; Cohen JL; Speck J; Tint GS; Shore V; Dayal B; Chen T; Shefer S
    J Lipid Res; 1985 Sep; 26(9):1126-33. PubMed ID: 4067433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse relationship between plasma cholestanol concentrations and bile acid synthesis in sitosterolemia.
    Salen G; Batta AK; Tint GS; Shefer S; Ness GC
    J Lipid Res; 1994 Oct; 35(10):1878-87. PubMed ID: 7852865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations.
    Nguyen LB; Salen G; Shefer S; Tint GS; Ruiz F
    Metabolism; 2001 Oct; 50(10):1224-9. PubMed ID: 11586498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis.
    Nguyen LB; Shefer S; Salen G; Ness GC; Tint GS; Zaki FG; Rani I
    J Clin Invest; 1990 Sep; 86(3):923-31. PubMed ID: 2394840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cholesterol biosynthesis in sitosterolemia with xanthomatosis: diminished mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and enzyme protein associated with increased low-density lipoprotein receptor function.
    Nguyen LB; Salen G; Shefer S; Tint GS; Shore V; Ness GC
    Metabolism; 1990 Apr; 39(4):436-43. PubMed ID: 2325562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of abnormal plasma and cellular sterol content and composition on low density lipoprotein uptake and degradation by monocytes and lymphocytes in sitosterolemia with xanthomatosis.
    Nguyen LB; Shefer S; Salen G; Horak I; Tint GS; McNamara DJ
    Metabolism; 1988 Apr; 37(4):346-51. PubMed ID: 3357417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues.
    Connor WE; Lin DS; Pappu AS; Frohlich J; Gerhard G
    Lipids; 2005 Sep; 40(9):919-23. PubMed ID: 16331855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotes.
    Shefer S; Salen G; Bullock J; Nguyen LB; Ness GC; Vhao Z; Belamarich PF; Chowdhary I; Lerner S; Batta AK
    Hepatology; 1994 Jul; 20(1 Pt 1):213-9. PubMed ID: 8020891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7 alpha-hydroxylase.
    Shefer S; Salen G; Nguyen L; Batta AK; Packin V; Tint GS; Hauser S
    J Clin Invest; 1988 Dec; 82(6):1833-9. PubMed ID: 3143743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction.
    Nguyen LB; Cobb M; Shefer S; Salen G; Ness GC; Tint GS
    J Lipid Res; 1991 Dec; 32(12):1941-8. PubMed ID: 1816322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
    Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
    J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia.
    Salen G; von Bergmann K; Lütjohann D; Kwiterovich P; Kane J; Patel SB; Musliner T; Stein P; Musser B;
    Circulation; 2004 Mar; 109(8):966-71. PubMed ID: 14769702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.